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INTRODUCTION
The study of membrane traffic is now
a well-established area of research, and
one that has resulted in several Nobel
prizes including ones awarded to Albert
Claude, George Palade, and Christian
DeDuve in 1974, Michael Brown and
Joseph Goldstein in 1985, Gunter Blobel in
1999, and most recently James Rothman,
Randy Schekman, and Thomas Südhof
in 2013. As a result of their studies and
other research, we now have fundamental
insights into the organization and routes
of transport between the cells’ mem-
branous organelles. Moreover, we have
defined the basic “cellular machinery”
that governs protein and lipid synthesis,
that ensures selective recognition of pro-
teins and lipids, and that promotes vesicle
fission, transport, and fusion. In addi-
tion, we have a large number of insights
into the regulatory molecules that con-
trol these processes including the Rab
GTPases and their effectors. While the
challenges for the future are many, this
essay is focused on areas of investiga-
tion that we see as moving forward at
a rapid pace, which speak to how mem-
brane traffic contributes to overall cell
and tissue function, and which are likely
to provide important avenues of funding
for both established and new investiga-
tors. These challenges include how mem-
brane traffic is regulated in response to
metabolic needs, how molecules are trans-
ferred between organelles, how membrane
traffic is regulated and functions during
processes such as development, and how
membrane traffic is used by highly differ-
entiated cells to perform specialized cell
functions.
HOW IS MEMBRANE TRAFFIC
REGULATED IN RESPONSE TO
METABOLIC NEEDS?
Membrane traffic is known to be regulated
by extracellular cues including growth fac-
tors and neurotransmitters; however, sig-
nificantly less is known about how the cell
modulates its membrane traffic to match
its metabolic needs. This is critical dur-
ing processes such as cell growth, where
membranes must be expanded in advance
of cell division. Moreover, many diseases
that affect large swaths of our population,
including diabetes and obesity, are essen-
tially metabolic disorders. Considering the
primary role that cells play in anabolism
and catabolism, understanding how these
processes are coordinated with membrane
traffic is a challenge that is very likely
to enjoy enhanced attention and future
research.
mTORC1, LYSOSOME BIOGENESIS, AND
AUTOPHAGY
An important regulatory pathway is the
mechanistic (previously mammalian)
target of rapamycin (mTOR), a ser-
ine/threonine kinase at the heart of mTOR
complex-1 (mTORC1) (Betz and Hall,
2013). This protein assembly also includes
Raptor, mLST8, Deptor, and PRAS40
(Jewell et al., 2013). mTORC1 plays a crit-
ical role in integrating growth control by
sensing the nutrient and energy status of
the cell along with the presence of growth
factors. When the cell is energy replete,
and amino acids are present, mTORC1
is recruited to lysosomal membranes by
the activity of the Ragulator (composed
of p14, p18, MP1, C7orf59, and HBXIP)
(Bar-Peled et al., 2012;Betz andHall, 2013)
(Figure 1). The Ragulator functions as a
guanine nucleotide exchange factor (GEF)
for the GTPases RagA/B, which act in
concert with RagC/D to recruit mTORC1
to the lysosomal membrane (Kim et al.,
2008; Sancak et al., 2008). Rag GTPase-
activating proteins (GAPs) have not been
identified and it is unknown if Rags cycle
on and off the lysosomal membrane.
Once recruited, and in a reaction that
depends on the Rheb GTPase, mTOR
is activated and stimulates ribosome
biogenesis and translation by phospho-
rylating the ribosomal S6 kinases, and
lipid synthesis (Figure 1). Rheb activity is
regulated by the tuberous sclerosis (TSC)
complex, which includes TSC1, TSC2,
and TBC1D7. Collectively, this complex
forms a Rheb-specific GAP that is neg-
atively regulated by growth factors that
act through Akt (Manning and Cantley,
2007). Whereas mTORC1 stimulates
biosynthetic pathways, activated mTORC1
negatively regulates lysosome biogenesis
and autophagy by phosphorylating and
preventing the nuclear translocation of
TFEB, a transcription factor that regulates
expression of genes that control lysosome
biogenesis and autophagy (Martina et al.,
2012; Roczniak-Ferguson et al., 2012)
(Figure 1).
Why recruit mTORC1 to the lyso-
some? Studies to date indicate that this
may be a critical mechanism to couple
mTORC1 activation to amino acid avail-
ability (Efeyan et al., 2012). In yeast, there
is significant evidence that the vacuole is
a storage site for amino acids, and mam-
malian lysosomes may perform a similar
function. Intriguingly, addition of amino
acids to purified lysosomes is sufficient to
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FIGURE 1 | Activation and function of the mTORC1 complex. Left:
Under conditions when amino acids are depleted, when energy levels are
low, or when DNA is damaged, the mTORC1 complex is inactive and
primarily cytosolic. Under these conditions, the transcription factor TFEB
enters the nucleus where it promotes the expression of genes necessary
for lysosome biogenesis and autophagy. Right: When amino acids are
elevated, the mTORC1 complex is recruited to the lysosomal membrane
by the combined effects of the Rag and Rheb GTPases. In its activated
state, mTOR phosphorylates several downstream targets including TFEB,
the autophagy regulatory factor ULK1, and the S6-kinases (S6K).
Phosphorylation of TFEB or ULK1 is inhibitory, while phosphorylation of
S6Ks leads to increased protein synthesis. mTORC1 is also activated by
growth factors such as the insulin receptor (IR). Upon insulin binding, a
signaling cascade is initiated by the insulin receptor substrate 1 (IRS1) and
continues with recruitment of phosphoinositide-3-kinase (PI3K), the
3-phosphoinositide dependent protein kinase-1 (PDK1), and the Akt kinase.
The latter inhibits the activity of the tuberosclerosis complex (TSC), leading
to Rheb activation.
recruit mTORC1 to the organellar mem-
brane (Zoncu et al., 2011). These and
other data indicate that there is a mecha-
nism for amino acid uptake into the lyso-
some that controls Rag activation by an
inside-out mechanism that conveys infor-
mation about amino acid levels in the
lysosome lumen to the Rags and Ragulator
(Zoncu et al., 2011; Efeyan et al., 2012).
Interestingly, the vacuolar ATPase plays
an important but poorly understood role
in this process (Jewell et al., 2013). One
model is that amino acid transporter
function is linked to the proton gradi-
ents formed by the vacuolar (v)-ATPase
(i.e., symport or antiport mechanisms).
However, an alternative model is that the
v-ATPase functions by maintaining the pH
of the lysosome and/or the pH of the
cytoplasm. In either case, there is lim-
ited understanding of how amino acids
are transported into the lysosome or how
this information is transferred in a v-
ATPase dependent manner to mTORC1
recruitment. To add to the complexity,
there may be a mechanism for cytoplas-
mic sensing of leucine, which involves the
leucyl-tRNA synthetase and RagD (Bonfils
et al., 2012; Han et al., 2012). But how
this interaction is linked to mTORC1
localization and function remains to be
determined.
When amino acids fall below a poorly
defined set point, mTORC1 becomes
inhibited and is released from the lyso-
some into the cytosol. As a result, TFEB
is no longer phosphorylated by mTORC1.
In its dephosphorylated state, TFEB is
translocated into the nucleus where it
binds to the “coordinated lysosomal
expression and regulation” (CLEAR) pro-
moter elements that control expression of
several lysosomal and autophagy-related
genes (Palmieri et al., 2011; Roczniak-
Ferguson et al., 2012) (Figure 1).
Combined with dephosphorylation and
activation of the autophagy-inducing
kinase ULK1, there is massive formation
of autophagosomes, which undergo fusion
with lysosomes to create a hybrid organelle
that promotes degradation. In effect, the
cell increases the pool of available amino
acids by stimulating protein turnover.
Intriguingly, mTORC1 is subsequently
recruited to the autophagolyososomes
where it now stimulates the re-formation
of lysosomes that bud from the hybrid
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organelle (Yu et al., 2010; Efeyan et al.,
2012). What mTORC1 does to potentiate
this fission reaction is poorly understood.
While growth factors are an additional
mechanism for stimulating mTORC1 acti-
vation/lysosome recruitment, inhibitory
factors such as decreased energy levels,
which activate the AMP-regulated kinase
(AMPK), DNA damage, or hypoxia can
all act to prevent mTORC1 activation
and recruitment to the lysosome (Efeyan
et al., 2012) (Figure 1). Thus, a number
of stressful stimuli can target mTORC1-
regulated pathways such as lysosome
biogenesis and autophagy.
In addition to mTORC1, there is
an additional related complex called
mTORC2 (Betz and Hall, 2013). It is
comprised of mTOR, Rictor, SIN1, and
mLST8. This complex is known to reg-
ulate lipogenesis, glucose metabolism
(by way of the classical Akt pathway),
the actin cytoskeleton, and apoptosis.
Whereas mTORC1 is found prominently
at the lysosome, mTORC2 is located
at the endoplasmic reticulum (ER) and
mitochondria, and perhaps at the closely
apposed contact sites between mitochon-
dria and ER membranes (Betz and Hall,
2013). These so-called “membrane contact
sites” (MCSs) are described in more detail
below. What mTORC2 does at these sites
is unknown.
In summary, mTORC1/2 complexes
appear to play a critical role in match-
ing membrane traffic to intrinsic and
extrinsic cues such as cellular ATP and
amino acid levels, and the presence of hor-
mones (e.g., insulin) and growth factors
(e.g., EGF receptor ligands and insulin-
like growth factor 1). In autophagy and
lysosome biogenesis, there is a growing
understanding of how mTORC1 asso-
ciates with the relevant membranes and
how it upregulates these pathways upon
nutrient depletion. However, how or if
mTORC1/2 regulates other membrane
trafficking pathways is largely unexplored,
even though mTORC1 and/or MTORC2
are found at the plasma membrane,
mitochondria and peroxisomes, as well
as the nucleus (Betz and Hall, 2013).
Thus, an important future challenge is
to understand howmTORC complexes are
selectively recruited to membranes other
than lysosomes, to define the effectors
of mTORC1/2 at these disparate mem-
brane domains, and to establish how these
effectors stimulate/repress membrane
trafficking events.
SREBP AND LIPID METABOLISM
Understanding lipid metabolism is impor-
tant because lipids and sterols are criti-
cal precursors of steroid hormones, they
are the basis of several critical signaling
pathways in the cell, and they are key
components of cellular membranes. One
mechanism for sensing changes in choles-
terol levels requires the “sterol regulatory
element binding proteins” (SREBPs), three
subtypes of which have been identified
(Daemen et al., 2013). They are nomi-
nally ER resident proteins that are cleaved
by intramembrane proteolysis in response
to depletion of lipids and sterols (Wang
et al., 1994) (Figure 2). The released N-
terminal domain acts as a transcription
factor to stimulate lipid and sterol biosyn-
thesis by increasing gene expression of
proteins involved in cholesterol biogen-
esis (Hua et al., 1993; Yokoyama et al.,
1993; Wang et al., 1994). One target of
this transcription regulation is the LDL
receptor, a classical recycling receptor that
scavenges lipid-rich particles in the blood
(Brown and Goldstein, 1997). Additional
FIGURE 2 | SREBP cleavage and function. SREBP is a regulator of genes
involved in lipid metabolism. It has two critical domains: a regulatory one
(SREBP-Reg) that promotes interactions with SCAP, and one with a basic
helix-loop-helix structure (SREBP-bHLH), a structure characteristic of
transcription factors. Right: Under conditions where cholesterol levels are
elevated, SREBP is maintained in the ER via its interactions with SCAP, a
protein that has a sterol-sensing domain (SSD). SCAP is maintained in the ER
through inhibitory interactions with INSIG. Left: As cholesterol levels fall,
SCAP senses the change, disengages from INSIG, which is ubiquitinated (Ub)
and degraded. The SCAP/SREBP complex is then packaged into
COPII-coated vesicles. In the Golgi, SREBP is cleaved first by the
site-1-proteinase (S1P), and then the site-2-proteinase (S2P), releasing the
bHLH domain. This domain enters the nucleus where it stimulates the
transcription of genes involved in sterol biogenesis.
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targets include enzymes such as the HMG-
COA reductase, which catalyzes the rate-
limiting step in cholesterol biogenesis. The
function of SREBP depends on its associ-
ation with the “SREBP cleavage-activating
protein” (SCAP) (Figure 2), which has an
N-terminal sterol-sensing domain found
in other proteins including the HMG-
COA reductase, the Niemann Pick disease
type C1 protein, and Patched, a crit-
ical component of the Hippo pathway
(Hua et al., 1996; Daemen et al., 2013).
In response to sterol depletion, SCAP
is thought to change its conformation,
releasing it from the effects of an inhibitory
protein called the “insulin-induced gene”
(Insig) (Sever et al., 2003). Active SCAP
then interacts with SREBP, promoting
COPII-dependent transport of SCAP-
SREBP from the ER to the Golgi complex,
where SREBP is cleaved by SP2 (Figure 2).
There is a growing realization that
the SREBP pathway is not just regu-
lated by lipids/sterols, but also by glucose,
insulin, and other metabolic intermedi-
ates (Daemen et al., 2013). In the case
of insulin, the PI3K/Akt pathway may
play a critical role by regulating the traf-
fic of the SCAP-SREBP complex from the
ER to Golgi by phosphorylating SREBP-
1c and thus modulating its affinity for
Sar1p and Sec23/24 at the expense of
interactions with Insig (Yellaturu et al.,
2009a,b). The latter may show increased
degradation in the presence of insulin.
Furthermore, a major downstream regula-
tor of the PI3K/Akt pathway is mTORC1,
which positively regulates SREBP process-
ing (Porstmann et al., 2008), possibly
by phosphorylating the S6 kinase (Owen
et al., 2012). There is also an intrigu-
ing connection between SREBP-2 and the
“activating transcription factor-6” (ATF6),
an ER membrane-bound transcription
factor that like SREBP is proteolytically
cleaved at the Golgi. This proteolysis
releases a transcription factor that binds
to nuclear SREBP-2, down-regulating its
gene expression (Zeng et al., 2004).
Importantly, ATF6 is stimulated by the
accumulation of misfolded or unfolded
proteins during ER stress, which may
occur in response to glucose deprivation
(Brewer, 2014). Thus, in the absence of
glucose, lipid and cholesterol biosynthesis
may be downregulated to conserve energy.
Other examples of metabolic pathways
regulating SREBP include polyunsatu-
rated fatty acids, glutamine, the NAD+-
dependent deacetylase SIRT1, fibroblast
growth factor 21, and retinol binding pro-
tein (Daemen et al., 2013). How these
impinge on trafficking of SREBP is an
open question.
Although now a well-established path-
way, there is much work to be done to
understand the genes targeted by SREBPs.
In myotubes, greater than a thousand
genes may be upregulated or downreg-
ulated in response to SREBP activation
(Rome et al., 2008). Of note is the number
of membrane trafficking-associated genes
that are affected including the nominally
epithelial specificμ1b adaptin, the clathrin
light chain, the COPII coat protein com-
ponent Sec23B, the v-SNARE VAMP3, the
exocyst subunit Sec6, Rab33A, and a large
number of microtubule/myosin motors to
name a few (Rome et al., 2008). Why
these particular genes are targeted and the
specific membrane trafficking events they
control in response to SREBP regulation
remains to be determined. Finally, there
is an increasing realization that SREBP-2
may also regulate a diversity of other cellu-
lar functions including autophagy, phago-
cytosis, membrane repair, and cell cycle
control (Daemen et al., 2013).
LIPID DROPLETS
Lipid droplets (LDs) are an accumu-
lation of lipid esters (triacylglycerides,
steryl esters, and diacylglycerol) bound
by a phospholipid monolayer that also
contains cholesterol and peripheral pro-
teins (Ohsaki et al., 2014; Pol et al.,
2014). Because excess lipid accumula-
tion is observed in obesity, diabetes, and
atherosclerosis, the functions of LDs are
of enormous interest. Moreover, LDs are
linked to autophagy, and apparently play
an important, albeit, ill-defined role in
regulating the turnover of cellular lipids.
Furthermore, pathogens such as hepatitis
virus type C and Chlamydia trachomatis
are thought to use LDs for their growth.
LDs are present in all cells, but particu-
larly rich in white adipocytes where they
form one large droplet of a size >100μm.
In other cell types LDs are much smaller
(∼0.5–5μm in diameter), and more
numerous. There is some compositional
heterogeneity in LDs, with some con-
taining predominantly triglycerides (TGs),
while others are enriched in steryl esters
(Ohsaki et al., 2014). Peripheral proteins
associated with LDs include the perilip-
ins (1–5 isoforms); however, proteomic
studies indicate the presence of more
than 200 proteins, many of which are of
unknown function in LD biology (Hodges
and Wu, 2010). Kinesin and dynein are
associated with LDs, likely explaining
the long-range, microtubule-dependent
movements of some of these organelles
(Welte, 2009). LDs are closely apposed to
the ER, their likely site of biosynthesis,
as well as mitochondria and peroxisomes
(Ohsaki et al., 2014); however, the mech-
anisms by which these organelles inter-
act are not well-understood and open
to further investigation. One possibility,
described below, is that LDs form MCSs
with proteins in the ER membrane.
An important, but unanswered
question is the mechanism(s) of LD
biosynthesis. Interestingly, LDs contain
diacylglycerolacyltransferase 2 (DGAT2),
an integral membrane enzyme that cat-
alyzes the final steps of TG synthesis
(Harris et al., 2011; Wilfling et al., 2013).
The current model is that LDs are formed
in the ER membrane (Ohsaki et al., 2014).
As the concentrations of TGs or steryl
esters increases to a few mole %, they
are thought to aggregate, and become
sequestered between the leaflets of the ER
membrane, i.e., the nascent LD lumen.
They may then bud off the ER membrane
or may be formed as a result of matura-
tion of ER-associated vesicles. Subsequent
to their formation, LDs are thought to
grow by a number of mechanisms includ-
ing LD-LD fusion (apparently a rare event
under most laboratory conditions), or TG
transfer between closely apposed LDs, a
function that depends on Perilipin-1, “fat
storage-inducing proteins” FIT1/2, Fsp27,
and local TG synthesis driven by DGAT2
(Chang et al., 2006; Gong et al., 2011; Sun
et al., 2013; Wilfling et al., 2013).
The machinery that promotes early LD
formation is the subject of active research.
Using a genome-wide siRNA screen in
Drosophila S2 cells, some 227 genes were
identified that alter the morphology of
LD formation (Guo et al., 2008). The 132
genes with marked phenotypes sort into
five categories. Class I genes show reduced
numbers of LDs and included the dia-
cylglycerolacyltransferase protein Midway,
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and subunits of the spliceasome and pro-
teasome. Class II genes result in smaller,
dispersed LDs and included dynein and
RNA polymerase II subunits. Class III
genes show dispersed droplets that were
a bit larger than normal. Intriguingly,
the genes include members of the Arf1-
COP1 vesicular transport machinery—a
striking finding. Class IV genes result in
clusters of LDs and Class V genes con-
tained one or more very large droplets.
Genes in the latter category include SREBP
and SCAP.
Arf1-COP1 complexes are involved in
retrograde transport from the Golgi appa-
ratus to the ER, and also play roles at the
TGN and in endosomes. COPII has also
been implicated in LD biogenesis (Soni
et al., 2009), but this finding is contro-
versial (Guo et al., 2008). The function
of Arf1-COPI in LD biogenesis is still
being resolved. Initial studies indicated
that Arf1-COP1 were involved in lipol-
ysis, and consistent with this possibility
is the observation that Arf1-COPI regu-
lates the delivery of adipose triglyceride
lipase to droplets (Soni et al., 2009; Ellong
et al., 2011). Moreover, enzymes involved
in LD biogenesis are also transported to
LDs in an Arf1-COP1-dependent manner
(Wilfling et al., 2014). How Arf1-COP1
promotes these transfers is a matter of
conjecture. One possible model is that
Arf1/COP1 acts to recognize cargoes and
promote their targeting to LDs in a man-
ner similar to how this coat functions in
the biosynthetic pathway. However, a more
recent analysis indicates that Arf1-COP1
directly associates with LDs, and may
function to stimulate the budding of nano-
droplets from their surfaces (Wilfling et al.,
2014). In turn, these budding events are
proposed to affect LD surface tension in
a manner that promotes formation of
MCSs between the LD and the ER. Once
formed, the MCS then allows for pro-
teins to transfer from the ER to the LD
particle. It is worth noting that in these
studies association of Arf1-COPI on LDs
is highly discrete and focused (Wilfling
et al., 2014), indicating that if Arf1-COP1
regulates nano-droplet formation, then it
does so at localized sites on the LD. In
addition to its effects on LDs, Arf1-COP1
could also regulate the ER lipid composi-
tion, and in doing so regulate the transfer
of proteins/lipids at ER-LD MCSs.
Because of their association with
metabolic disorders such as diabetes,
studies of LD biogenesis, catabolism, and
function are rapidly multiplying. Yet, there
remains a large number of unresolved
questions including how LDs are formed
and the mechanisms of their turnover. For
example, E2 and E3 ubiquitin ligases are
associated with LDs (Ohsaki et al., 2014).
Could their function be to regulate the
degradation of LD-associated proteins?
Somewhat unexpectedly, LDs also appear
to play a role in protein degradation and
sequestration (Ohsaki et al., 2014), as well
as regulation of histone H2Av availabil-
ity during development (Li et al., 2014).
As noted above, Class I genes include
subunits of the proteasome (Guo et al.,
2008). Moreover, proteins such as ApoB,
which is associated with nascent very low-
density lipoprotein particles, accumulate
in LDs when the proteasome is inhib-
ited (Fujimoto and Ohsaki, 2006; Ohsaki
et al., 2006), and the HMG-CoA reduc-
tase localizes to the LD fraction prior to
extraction and degradation by the pro-
teasome (Hartman et al., 2010). This
indicates that for some proteins, their
ER-associated degradation likely involves
passage through LDs. However, the exact
function of LDs in this regard is unknown.
PRESSING QUESTIONS IN THE REGULATION
OF MEMBRANE TRAFFIC BY CELLULAR
METABOLISM
Perhaps one of the grandest challenges
in metabolism research today is to
understand how nutrient status, lipid
metabolism, membrane biogenesis, and
organelle homeostasis are coordinated.
Data thus far point to mTORC1/2 as the
potential brains behind these operations
as they receive sensory input from a num-
ber of external/internal sources and then
transduce these signals by targeting signal-
ing pathways that up- or down-regulate
relevant membrane trafficking pathways.
Thus, under conditions where metabo-
lites are readily available, mTORC1/2
complexes act to decrease TFEB function
(Palmieri et al., 2011; Roczniak-Ferguson
et al., 2012), ensuring the cell does not
devote excessive energy for degrading
macromolecules in lysosomes or per-
forming autophagy. Instead, more energy
can be spent storing triglycerides in LDs,
and by increasing the synthesis of sterols
and lipids by way of SREBPs (Porstmann
et al., 2008; Owen et al., 2012). The latter
would allow the cell to match the increase
in metabolic need with a correspond-
ing increase in membrane biogenesis
and traffic. In contrast, under nutrient
poor conditions, mTORC1/2 activity is
suppressed, leading to a stimulation of
lysosome and autophagasome biogenesis,
and an increase in triacylglycerol lipolysis
(Soliman et al., 2010). Starvation is also
likely to result in a general downregulation
of membrane traffic.
If our premise is correct, then one of the
big questions that needs to be addressed
is the identity of the mTORC1 effector
molecules and their targets. In the case
of lysosomes and autophagasomes, TFEB
is one effector. But, are there other effec-
tors, including those that act more acutely?
In the case of SREBPs, the target of the
S6 kinase is not yet established, and it is
unknown whether there are effectors other
than the S6 kinase. Moreover, in the case
of LDs and other membrane trafficking
pathways there is a paucity of information
about the identity of the mTORC1/2 effec-
tors and targets. Furthermore, we have
limited knowledge about the extent of the
crosstalk in between the trafficking path-
ways, or how this cross-communication
might be regulated. This is likely to be
very important, because as noted above an
increase in membrane traffic and organelle
biogenesis must be coupled to increased
availability of components such as lipids.
Finally, an important goal is to under-
stand how metabolic pathways are altered
by disease, and how this impacts mem-
brane traffic and the attendant changes in
cell function that arise.
HOW DO ORGANELLES EXCHANGE
CONTENT AT MEMBRANE CONTACT
SITES?
While membrane traffic often involves the
movement of membranes and their car-
goes via tubulovesicular carriers, MCSs
are regions of close contact between
organelles (less than 30 nm) that promote
the exchange of Ca2+ and/or lipids (Helle
et al., 2013; Prinz, 2014). Understanding
howMCSs are formed, how they function,
and how they are regulated is an additional
challenge for our field. Formation of the
MCS is thought to depend on tethering
complexes, which bring the membranes in
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close proximity. In turn, these tethering
complexes may recruit effector molecules
that promote content exchange between
organelles. However, in some cases tether-
ing factors may also have effector function
(see below). Reflecting its role as a major
cellular site of lipid synthesis and Ca2+
storage, the ER forms MCSs with multiple
organelles including: mitochondria, lyso-
somes, LDs, the Golgi apparatus, endo-
somes, and the plasma membrane (Helle
et al., 2013; Prinz, 2014). However, we
are likely to find other examples of inter-
organellar interaction/communication as
cell biologists look more closely. It is
not known whether molecules other than
Ca2+ and lipids are transferred at MCSs,
but it is formally possible. Indeed, MCS-
associated proteins are reported to have
other functions including regulation of
microautophagy, regulation of mitochon-
drial dynamics, and regulation of vesicular
trafficking pathways (Helle et al., 2013).
An example of the latter is described
below.
A PLASMAMEMBRANE-ER MCS THAT
PROMOTES Ca2+ UPTAKE IN RESPONSE TO
STORE DEPLETION
A variety of cellular processes including
sensory perception, cell migration, muscle
contraction, transcription, T-cell activa-
tion, and regulated secretion depend on
the sustained release of Ca2+ from the ER,
the major intracellular site of Ca2+ stor-
age (Soboloff et al., 2012; Hooper et al.,
2013). However, once the Ca2+ stores
are depleted their replenishment depends
on a process called “store-operated Ca2+
entry.” This function depends on two
families of proteins: the stromal inter-
action molecules (STIM) 1/2, which act
as Ca2+ sensors, and Orai1-3 (Soboloff
et al., 2012; Hooper et al., 2013). The latter
are plasma membrane-associated, Ca2+
release-activated channels (a.k.a. CRACs)
that serve as conduits for Ca2+ entry into
the ER. Mutations in STIM1 or Orai1
lead to severe immunodeficiencies, con-
firming the importance of these proteins
in normal cellular function (Mccarl et al.,
2009; Picard et al., 2009; Feske et al.,
2010).
STIM1 is a type 1 transmembrane pro-
tein that is localized primarily at the ER.
Its structure has been partially solved
(Soboloff et al., 2012; Yang et al., 2012;
Stathopulos and Ikura, 2013). At Its
N-terminus lies a canonical Ca2+-binding
EF-hand domain, which is located in the
ER lumen, and works in conjunction with
a non-canonical EF-hand domain and
SAM (sterile α motif) domain to sense
Ca2+ depletion. At resting luminal ER
Ca2+ concentrations (∼400μM), STIM1
is distributed throughout the ER; however,
as ER Ca2+ stores are depleted, STIM1
(which binds Ca2+ with a KD of 200μM)
is presumed to undergo a large conforma-
tional change that leads to rapid oligomer-
ization of the molecule (Figure 3A). This
is coupled to translocation of STIM1 to
an ER-plasma membrane MCS. This pro-
cess depends, in part, on a poly-lysine
tract at the C-terminus of STIM1 that
allows for it to interact with lipids (Liou
et al., 2007; Korzeniowski et al., 2009).
The movement of STIM1 is followed by
migration of Orai1-3 to the MCS, where
it interacts with the STIM-Orai activat-
ing region (SOAR) found in the cytoplas-
mic domain of STIM1 (Yang et al., 2012)
(Figure 3A). The Orai channels have four
transmembrane domains with cytosolic
N- and C-termini. The functional regions
of the channel are being defined using
both structural and mutational analyses
(Yeromin et al., 2006; Mcnally et al., 2009;
Feske et al., 2010; Lis et al., 2010; Zhang
et al., 2011; Liu et al., 2012; Mcnally
and Prakriya, 2012; Stathopulos and Ikura,
2013). The precise mechanisms by which
Orai channels interact with STIM1 and
how these interactions promoteOrai activ-
ity will require further research. However,
the interaction is likely to be direct as
recombinant STIM cytosolic fragments are
sufficient to increase Ca2+ import in yeast
expressing Orai channels (Zhou et al.,
2010). Other work indicates that the C-
terminal tail of Orai1 contains a cluster
of acidic residues that may interact with
basic amino acids in the SOAR domain of
STIM1 (Calloway et al., 2009).
One mystery is how Ca2+ entering the
Orai channel is funneled into the ER and
prevented from rapidly diffusing into the
cytosol. A possible mechanism is the local-
ization of the sarcoplasmic reticulum/ER
Ca2+ ATPase (SERCA) to the ER-plasma
membrane MCS (Figure 3A). SERCA is
responsible for transporting cytosolic
Ca2+ into the ER against a steep con-
centration gradient. Interestingly, SERCA
appears to associate with STIM1/Orai1
(Lopez et al., 2008; Manjarres et al., 2010),
indicating that MCS-localized SERCA
may be critical for refilling ER stores.
Furthermore, it demonstrates that STIMs
and perhaps Orai1 channels may recruit
effectors that can regulate the process of
Ca2+ exchange between these two mem-
branes. This appears to be true of other
MCSs as well, and various effectors have
been proposed (Helle et al., 2013).
How the ER and plasma membrane
are tethered at the STIM1/Orai1 MCS
is not known. One possibility is that
STIM and Orai act as a tethering com-
plex; indeed, overexpression of STIM1
leads to increased numbers of ER/PM con-
tact sites (Wu et al., 2006; Lur et al.,
2009). Moreover, TIRF studies indicate
that STIM1 may cycle at defined ER-PM
MCSs (Smyth et al., 2008). But if true,
then it becomes difficult to envision how
ER-PM MCSs are maintained and reused,
unless a small number of STIM and Orai
molecules remain at contact sites and form
a nidus for expansion of the MCS upon
Ca2+ depletion. In addition to STIM1,
tagged-Orai1 also appears to traffic to ER-
PM MCSs (Woodard et al., 2008); how-
ever, if its Ca2+-dependent redistribution
reflects vectorial traffic or diffusion in the
plane of the plasma membrane remains
to be determined. Moreover, endogenous
Orai1 may not undergo the same degree of
clustering as observed for overexpressed,
tagged versions of Orai1 (Hong et al.,
2011), indicating the degree of cluster-
ing at MCSs may be overestimated using
overexpression systems.
NON-VESICULAR LIPID EXCHANGE AT MCSs
In addition to Ca2+ exchange, MCSs are
also sites of non-vesicular lipid exchange
(Helle et al., 2013). This exchange is medi-
ated by lipid transport proteins (LTPs),
which bind a variety of lipid species via
their lipid transport domains. Indeed,
many LTPs can bind two lipid species in
a mutually exclusive manner. For exam-
ple, the ceramide transporter CERT binds
either ceramide or diacylglycerol, and thus
may promote lipid exchange (Kudo et al.,
2008). LTPs are targeted to MCSs by
way of specific interaction domains that
allow these molecules to bridge organel-
lar compartments. For example, CERT and
some “oxysterol-binding protein-related
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FIGURE 3 | Function of membrane contact sites in the cell. (A)
Ligand-bound growth factor receptor stimulates activation of phospholipase
C-γ (PLC γ), which hydrolyzes phosphatidylinositol 4,5-bisphosphate into
diacylglycerol (DAG), and inositol 1,4,5-trisphosphate (IP3). The latter binds
to the ER-localized IP3 receptor, triggering the release of Ca2+ from ER
stores. The released Ca2+ has several functions including activation of
“nuclear factor of activated T cells” (NFAT), a family of five proteins that
regulate transcription of genes required for development and differentiation.
In response to a large stimulus or when long-term elevation of Ca2+
occurs, the ER stores become depleted. The change is sensed by the
N-terminal, EF-hand domain (EFH) of STIM, resulting in the translocation of
STIM to MCSs closely apposed to the plasma membrane. This
relocalization is facilitated by a C-terminal polybasic tract of amino acids
(green spheres in STIM structure) that promote interactions with lipids in
the plasma membrane. Recruitment of Orai channels is potentiated by the
“STIM-Orai activating region” (SOAR), a domain in STIM that is thought to
induce a conformational change in Orai, leading to Ca2+ entry into the cell
cytoplasm. The refilling of ER Ca2+ stores is likely facilitated by close
apposition of SERCA with the STIM/Orai complex. (B) In the absence of
cholesterol, late endosomes become less motile, collect at the cell
periphery, and the LPT ORP1L promotes the formation of an MCS
between the ER and the late endosome. ORP1L does so by binding the ER
protein VAP (via its diphenylalanine in an acidic tract domain, FFAT), and
simultaneously binding lipids (via its pleckstrin homology domain, PHD) and
Rab7 (via its ankyrin repeat domain, ARD), a GTPase present on late
endosomes. As cholesterol levels rise, possibly as a result of cholesterol
transfer from the ER, the “oxysterol recognition domain” (ORD) of ORP1L
binds cholesterol. This interaction disengages the link between the FFAT
domain and VAP, and promotes the recruitment of the p150Glued
component of cytoplasmic dynein by way of the Rab7 effector RILP. When
fully assembled, the dynein motor promotes minus-end directed
movements of late endosomes, causing them to accumulate centripitally.
proteins” (ORPs) such as ORP1L have an
FFAT (diphenylalanine in an acidic tract)
motif, which interacts with the ER resi-
dent protein VAP (VAMP-associated pro-
tein) (Loewen et al., 2003) (Figure 3B).
Moreover, these proteins have a pleck-
strin homology domain (PHD), which
binds to specific phosphoinositides on the
Golgi and plasma membrane (Lemmon
and Ferguson, 2001).
LTPs are important components of
MCSs that form between the yeast vac-
uole and nuclear ER (Osh1/Scs2-22 and
Vac8/Nvj1), the Golgi and ER (CERT
and VAP), and the LD. In the latter case,
the LD enzyme DGAT2 is thought to
interact with FATP1, an acyl-CoA syn-
thase that is present in the ER membrane
(Xu et al., 2012). An additional example
is the MCS that forms between Neiman
Pick C protein-positive late endosomes
and the ER (Van Der Kant et al., 2013).
The MCS in this case is likely formed
by VAP and ORP1L, and the cholesterol
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transfer that ensues may be important
for the biogenesis of the intraluminal
vesicles that form in the lumen of late
endosomes/multivesicular bodies (Rocha
et al., 2009). MCS formation between the
ER and late endosomes is only observed
when cholesterol levels in the cell are low,
a change that is apparently detected by
ORP1L’s ORP-related domain (ORD), a
conserved domain found in ORP fam-
ily members (Helle et al., 2013). Because
late endosomes move centripetally, where
they accumulate in a peri-centriolar dis-
tribution, there must be a mechanism
to accommodate these movements dur-
ing MCS formation. Interestingly, ORP1L
has an additional function in this sys-
tem, one that uncouples late endosomes
from microtubules (Figure 3B). Under
conditions where cholesterol is replete,
Rab7 recruits the “Rab7-interacting lyso-
somal protein” (RILP), which associates
with the p150Glued subunit of the micro-
tubule dynein motor complex (Rocha
et al., 2009). As cholesterol levels drop,
binding of ORP1L’s FFAT domain to
VAP results in dissociation of dynein and
a redistribution of the late endosomes
toward the periphery. One possibility is
that the decrease in centripetal motion
facilitates the transfer of cholesterol
at the MCSs.
OPEN QUESTIONS IN MCS BIOLOGY
There are a significant number of
unknowns in the MCS field, ensuring that
analysis of these interactions will be an
active area of research for years to come.
For example, Helle et al. have defined a
number of reasonable criteria that would
establish a bona fide tether, but these cri-
teria have not been met for the majority
of putative tethering complexes (Helle
et al., 2013). Moreover, LTPs are though
to interact with two organelles simultane-
ously, but it is not clear whether this serves
as a mechanism to specify their localiza-
tion at the MCS or whether it serves to
tether membranes at these sites of inter-
action. Furthermore, there are reactions
in the cell that are likely to depend on
MCSs, but the critical components have
not been identified. For example, it has
been known for decades that de novo syn-
thesis of phosphatidylethanolamine (PE)
and phosphatidylcholine (PC) requires
a close interaction between the ER and
mitochondria. While phosphatidylser-
ine (PS) is synthesized in the ER by
the PS synthase, the formation of PE
is dependent on a decarboxylase that
resides in the inner mitochondrial mem-
brane. Finally, PE is converted in the ER
by a series of methylation steps to PC,
which requires the activities of the phos-
phocholine cytidylyltransferase enzymes
Cct1 and Cct2. Despite the importance
of these reactions, the LTPs and teth-
ering factors remain unknown (Helle
et al., 2013). Interestingly, Cct1 and Cct2
associate with LDs when triglyceride pre-
cursors are fed to cells, indicating that
LDs may play a critical role in this pro-
cess (Krahmer et al., 2011). Furthermore,
it indicates the PC synthesis may require
the formation of multiple MCSs, but how
these are regulated and coordinated is
unknown. Additional questions in MCS
biology and function include: Are MCSs
dynamic or stable, and how does this affect
their functions? Since organelles such as
the ER form numerous contacts, how
does the activity of one MCS affect the
activity of others? How important is non-
vesicular vs. vesicular lipid transport in
the cell?
HOW IS MEMBRANE TRAFFIC
EXPLOITED DURING COMPLEX
PROCESSES SUCH AS DEVELOPMENT?
An additional challenge for our field is
to understand how the complex events
that occur during development are inti-
mately linked to exocytosis and endocy-
tosis. Development is a process whereby
a single cell undergoes cell division, its
progeny differentiate into a number of spe-
cialized cell types, and these differentiated
cells form higher order structures (e.g.,
organs) that allow for specialized func-
tions. We consider two types of mecha-
nisms where membrane traffic is critical to
achieving cell differentiation: one involves
cell surface receptor-ligand pairs and the
other depends on the formation of a con-
centration gradient. However, other devel-
opmental processes can be considered
as well, including cell migration, apop-
tosis, autophagy, lumen formation for
organ ducts, and processes such as epithe-
lialization and morphogenesis. Indeed,
most, if not all, developmental pro-
cesses are likely dependent on membrane
traffic.
NOTCH SIGNALING AND THE GENERATION OF
CELLULAR ASYMMETRY
Notch signaling is a pathway for cell-cell
communication that occurs during devel-
opment and promotes the formation of
tissue boundaries, differentiation of cells
arising from equipotent precursors, and
generation of different cell types after a
single asymmetric cell division (Furthauer
and Gonzalez-Gaitan, 2009; Yamamoto
et al., 2010). It is not limited to embry-
onic development, as it also occurs during
any process that involves differentiation
of precursor cells including normal tis-
sue turnover as well as regeneration in
response to injury. The following discus-
sion is adapted from a recently published
monograph (Apodaca et al., 2012).
Somewhat akin to SREBP signaling,
Notch signaling requires intramembra-
nous proteolysis and release of a peptide
fragment that acts as a transcription factor.
The process is initiated when amembrane-
boundDelta/Serrate/Lag2 (DSL) ligand on
the surface of a signal-sending cell binds
to the membrane bound Notch receptor
on a signal-receiving cell (Figure 4A). This
triggers the proteolysis of the extracellu-
lar, juxtamembrane region of Notch by
a membrane-bound ADAM family pro-
teinase. This is rapidly followed by further
cleavage of the intramembrane domain by
the γ-secretase, promoting the release of
the Notch intracellular domain (NICD).
This peptide fragment is transported into
the nucleus and triggers transcription
upon its association with CBF1-Su-
Lag1 (CSL) family cofactors. Changes in
gene expression in the Notch-expressing,
signal-receiving cell leads to cellular
asymmetry.
In addition to exocytosis, which ensures
the surface delivery of Notch, Delta,
ADAM, and γ-secretase, Notch signal-
ing is also dependent on endocytosis
(Yamamoto et al., 2010). In the case of
Notch, and its co-factor Sanpodo, inter-
nalization requires Numb, an adaptor that
links the receptor to the AP2 adaptor com-
plex. The function of Notch endocytosis
is not completely clear, but may serve to
“activate” the receptor prior to proteol-
ysis, or it may be required to promote
Notch proteolysis and signaling (see text
below). Delta is also endocytosed, but in
a process that depends on the E3 ubiq-
uitin ligase Neuralized or Mindbomb, as
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FIGURE 4 | Role of membrane traffic in Delta-Notch signaling. (A) In
canonical Notch signaling the signal-sending cell expressing
Delta/Serrate/Lag2 (DSL) ligands interacts with the Notch receptor on the
signal-receiving cell, ultimately leading to Notch-dependent changes in gene
expression. On the signal-sending cell, DSL ligands are ubiquinated by the
action of the E3 ligases Neuralized or Mindbomb. The ligand is endocytosed
in an epsin and dynamin-dependent manner (step 1), and then delivered to
early and recycling endosomes, from which the ligand can recycle to the cell
surface (step 2). The DSL ligand encounters Notch on the signal receiving
cell and the endocytosis of the ligand results in a pulling force (marked with
a green arrow) that dislodges the previously cleaved N-terminal extracellular
domain of Notch (the product of S1 cleavage) into the signal-sending cell,
promoting its “trans-endocytosis” (step 3), delivery to MVBs (step 4), and
then likely degradation in lysosomes (not shown). The pulling force
generated during ligand endocytosis triggers cleavage of Notch on the
signal-receiving cell by an ADAM metalloproteinase (S2 cleavage; step 5).
This is followed by S3 cleavage, which is mediated by the transmembrane
γ-secretase (step 6). The latter releases the Notch intracellular domain
(NICD), which enters the nucleus and associates with CBF1/Su(H)/Lag1 CSL
family transcriptional cofactors to activate target genes. The sites of S2 and
S3 cleavage are unclear, but may occur at the cell surface or within
endosomes. Notch signaling depends on dynamin and Numb, an adaptor
that links Notch to the α-adaptin of the AP2 adaptor complex. (B) Cell
lineage of the Drosophila mechanosensory bristle. pI cells, also called single
organ precrusors (SOPs), undergo asymmetric cell division to give rise to
pIIa and pIIb cells, which express DSL ligands or Notch, respectively. The
pIIb cell gives rise to a glial cell (which undergoes apoptosis) and a pIIIb cell
that like pI will give rise to a DSL ligand-expressing neuron and
Notch-expressing sheath cell. The pIIa cell gives rise to the DSL
ligand-expressing shaft cell and the Notch-expressing socket cell. The
organization of the mechanosensory bristle complex is shown in the bottom
right. (C–E) Membrane trafficking events leading to the asymmetric cell
division of the pI cell. (C) During division of the pI cell, Neuralized and
Numb are segregated into the emerging pIIb cell by the action of the Par
complex (not shown). Neuralized catalyzes ubiquitination of the DSL ligand,
promoting its dynamin- and epsin-dependent endocytosis and delivery to
Rab5-positive early endosomes and then SARA-positive MBVs. Likewise,
Notch is internalized in an AP2-, dynamin-, and Numb-dependent manner,
and then trafficked via Rab5-positive endosomes to SARA-positive MVBs.
Prior to cytokinesis, the SARA-positive endosomes containing DSL ligand
and Notch align along the central spindle (shown as lines in the figure) and
partition into the emerging pIIa cell. During the transition to cytokinesis the
DSL ligand and Notch assume an anti-parallel orientation in the forming
SARA-positive MVB, stimulating S2 cleavage. See Furthauer and
Gonzalez-Gaitan (2009) for an alternative mechanism of Notch activation in
MVBs. (D) As cytokinesis proceeds S3 cleavage occurs, releasing the NICD.
By this point the majority of SARA-positive MVBs have segregated into the
pIIa cells, while Rab11-positive recycling endosomes are seen to organize at
the centrosomal region of the pIIb cell. The concentration of these
endosomes likely ensures that internalized DSL ligands are recycled and not
targeted for degradation. (E) Asymmetric cell division is complete. The
endocytic organelles take up a somewhat random distribution in the
cytoplasm and in the pIIb cells SARA-positive MVBs reform using the
cytoplasmic pool of SARA that partitions equally during cytokineses. Notch
present in the pIIb cells is likely targeted to MVBs for degradation. Figure
and legend used with permission and is from Apodaca et al. (2012).
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well as the adaptor protein epsin (“liquid
facets” in fly speak), which binds to ubiq-
uitinated cargoes (Wang and Struhl, 2005).
One model suggests that internalization is
required to “activate” Delta, but the nature
of this activation is not well-understood
and recent studies indicate that endocy-
tosis and recycling of the Delta ligand
do not affect its affinity for, or interac-
tions with Notch (Shergill et al., 2012).
In epithelial cells, Delta may need to be
transcytosed and thus changes in ligand
distribution or its association with spe-
cific membrane domains may be critical
for its function. Why ubiquitin promotes
recycling/transcytosis and not degrada-
tion, and the signals in Delta ligands that
specify apical targeting are open questions.
An additional endocytosis-requiring step
is one that occurs upon Delta binding to
Notch. In this case, “pulling” of the lig-
and by the endocytic machinery may cause
a conformational change in Notch, trig-
gering its proteolysis, and uptake of the
Notch extracellular domain by Delta cell
in a process termed “trans-endocytosis”
(Figure 4A). In a recent study, optical
tweezers were used to show that upon
receptor binding, Delta ligands indeed
exert a pulling force, and this force gen-
eration is dependent on the activity of
Mindbomb, dynamin, epsin, and actin
(Meloty-Kapella et al., 2012). The fate
of the Notch extracellular domain and
the effect of it on Delta traffic are not
well-understood.
Intriguingly, membrane traffic also
plays a critical role in asymmetric cell divi-
sion, which generates different cell types
after a single mitotic event. This process
requires careful coordination of mem-
brane traffic, cell polarization, cytokinesis,
organellar movements, and changes in
gene expression. Asymmetric cell division
occurs during the formation of the four
cell types that give rise to the mechanosen-
sory bristles that cover the dorsal thorax of
the fly pupae (Meloty-Kapella et al., 2012).
These include the neuron, sheath, shaft,
and socket cells (Figure 4B). In the sensory
organ precursor cells (SOPs, also known as
pI), which express both Delta and Notch,
mitosis is accompanied by endocytosis
of Delta and Notch (Figure 4C). In both
cases the required endocytosis machinery
is partitioned into the emerging pIIb cell:
Neuralized along with epsin in the case
of Delta (Emery et al., 2005), and Numb
and AP2 in the case of Notch (Tong et al.,
2010).
Apparently, Delta is initially delivered
to SARA (Smad Anchor for Receptor
Activation)-positive MVBs (Figure 4C),
but its fate changes as cell division pro-
ceeds and Rab11a-positive endosomes are
established in the centrosomal region of
the nascent pIIb cell (Figure 4D). The
Rab11-positive endosomes are thought to
stimulate Delta recycling, preventing its
delivery to MVBs and rapid degradation
(Emery et al., 2005). In contrast, Notch
and its cofactor Sanpodo are primarily
targeted to the forming SARA-positive
MVBs, which segregate upon cell divi-
sion into the pIIa cells (Coumailleau et al.,
2009) (Figure 4D). However, after cytoki-
nesis, these endosomes re-form in pIIb
cells from the cytoplasmic pool of SMAD
(Figure 4E). In pIIb cells both Notch
extracellular and intracellular domains are
found in SARA endosomes. However, in
the SARA-positive endosomes of nascent
pIIa cell, the extracellular domain of
Notch, but not its intracellular domain,
are present, indicating the Notch activa-
tion has occurred concurrent with cell
division (Figure 4D) (Coumailleau et al.,
2009). The question is where did the Notch
activation occur? If at the cell surface, it
may indicate that the NICD was released
en route to or within the SARA endo-
somes. However, an alternative possibil-
ity is that Delta and Notch differentially
partition into the limiting membrane of
the SARA MVB or the intraluminal mem-
branes. This would then allow for a pro-
ductive antiparallel interaction that would
promote Notch cleavage and release of
its intracellular domain (see Figure 4D).
Consistent with this model are previ-
ous studies that show Notch signaling is
dependent on ESCRT complex proteins
(Vaccari and Bilder, 2005). Regardless of
the site of activation, these studies empha-
size the critical role that vectorial mem-
brane traffic in promoting Notch signaling
and cell differentiation. Furthermore, the
discussion above indicates that even in
this well-studied system, a number of
unanswered questions remain.
MORPHOGEN GRADIENTS
An additional developmental mecha-
nism that affects cell differentiation is
the formation of morphogen gradients
(Erickson, 2011; Rogers and Schier, 2011;
Bokel and Brand, 2013). In these gradients,
a cellular population secretes a mediator
(i.e., morphogen), which moves outwards
and affects the developmental fate of adja-
cent cells as a function of their position in
the gradient. Because not all gradients are
identical in their range or effects, impor-
tant questions include: how the gradient is
formed, how it is shaped, and how cells are
able to differentially respond to the con-
centration of morphogen? Early models
posited that the shape of the gradient is
determined primarily by the rate of mor-
phogen secretion and its diffusion (Turing,
1990). However, other investigators argued
that diffusion alone cannot explain how a
gradient of cell fates is established, as dif-
fusion ultimately leads to the saturation of
all cells with morphogen (Wolpert, 1969).
Furthermore, simple diffusion models are
not thought to explain why some mor-
phogens can undergo rapid diffusion
in all directions, but the gradients they
generate form slowly, directionally, and
involve both extracellular and intracellular
gradients (Rogers and Schier, 2011).
To explain these later observations,
investigators have proposed a restricted
diffusion model, which posits that
morphogen spreading is affected by
interactions with cognate receptors, or
interactions with extracellular matrix
components. For example, the secreted
morphogen fibroblast growth factor (FGF,
which has 22 isoforms in mammals)
interacts with heparin sulfate (and other
sulfated oligosaccharides), which alters
the rate and extent of diffusion (Bokel
and Brand, 2013). Furthermore, some
morphogens such as BMP interact with
potentiators and/or inhibitors, and in
some cases morphogens are lipid modi-
fied or found within the cell cytoplasm of
syncitia (Erickson, 2011).
In addition to the above models, it
is now established that endocytosis is
key to gradient formation and cellular
responses to morphogens. In the prevail-
ing synthesis-diffusion-clearance (SDC)
model, morphogens are secreted and then
diffuse outwards. The shape of the gra-
dient is then determined by the clear-
ance, i.e., degradation, of the morphogen
and its cognate receptor (Wartlick et al.,
2009). In this model, the higher the rate
Frontiers in Cell and Developmental Biology | Membrane Traffic September 2014 | Volume 2 | Article 52 | 10
Apodaca and Brown Challenges in membrane traffic research
of diffusion and the lower the clearance
rates, the shallower the gradient will be.
Studies of FGF gradients provide evi-
dence in support of such a model. In
this case, blocking endocytosis by inhibit-
ing dynamin results in a less steep gradi-
ent, extends the FGF lifetime (i.e., blocks
its degradation), and increases the cellu-
lar zone where target gene expression is
upregulated (Yu et al., 2009a; Nowak et al.,
2011). In contrast, increasing endocytosis
by expressing Rab5c causes a steeper gra-
dient and reduces ligand half-life. While
lysosomal degradation is an integral part
of these models, there are few experiments
that directly examine how lysosomal tar-
geting and degradation (well-understood
and highly regulated processes) impact
morphogen gradient formation.
Other models for gradient formation,
include the “active transport model,” in
which morphogens are endocytosed and
then “re-secreted” by a so-called “pla-
nar transcytosis mechanism” (Entchev
et al., 2000; Entchev and Gonzalez-Gaitan,
2002). The exocytosedmorphogen is taken
up by an adjacent cell, which can repeat the
process. Such a mechanism would allow
gradients to form relatively slowly, and
across cell layers, as well form morphogen
gradients intracellularly and extracellu-
larly. This model may explain some facets
of the anterior/posterior gradient formed
by the TGF-β homolog Decapentaplegic
(Dpp) in the Drosophila wing disc, a flat
epithelial pouch that will give rise to
the wing and its associated structures.
Consistent with an important role for
endocytosis in gradient formation, the
majority of Dpp in the signal receiving
cells is found in endosomes (Entchev
et al., 2000). Internalization of Dpp is
reported to be dependent on the Dpp
receptor Thickveins, and Dpp gradients
are dependent on Rab5 function (Entchev
et al., 2000). Intriguingly, and unlike sim-
ilar experiments performed with FGF, no
gradient forms across cells that express
a temperature-sensitive mutation of the
dynamin homolog Shibire. Moreover,
Dpp-GFP fails to move across intervening
clones of dynamin-defective cells, leaving
a “shadow” in their wake where no gradi-
ent is formed even though these adjacent
cells express Shibire (Entchev et al., 2000).
At present there is limited genetic or mor-
phological evidence showing that recycling
or planar transcytosis is occurring or that
reuptake by adjacent cells is required for
gradient formation. Furthermore, the
function of planar transcytosis in Dpp
gradient formation has recently been ques-
tioned (Zhou et al., 2012b). The shape
of the Dpp gradient is also affected by
Rab7 overexpression, or by Rab7 mutants
that stimulate degradation (Entchev et al.,
2000). In this case, the gradient of activa-
tion was made shallower. Thus, regardless
of the mechanism of morphogen transfer,
a role for morphogen degradation is still
likely to be key for shaping the gradient.
If planar transcytosis also occurs, then it
indicates that changes in the regulation of
recycling vs. degradation may have critical
roles in regulating the shape and reach of
the gradient.
An important consequence of form-
ing a morphogen gradient is that cells
within the gradient are exposed to dif-
ferent concentrations of the morphogen.
By responding to distinct concentration
thresholds, the target cell then modulates
the expression of different target genes.
A well-known function of endocytosis in
general, and endosomes in particular, is
to regulate signal transduction (Gonnord
et al., 2012). In the case of TGFβ, the
mammalian ortholog of Dpp, the internal-
ized receptor-TGFβ complex is delivered
to endosomes where they encounter the
FYVE-domain containing protein SARA
(Murphy, 2007), which as described in
the previous section is associated with
multivesicular/late endosomes. This pro-
tein then recruits the transcription factor
Smad2, which traffics to the nucleus upon
release from the endosome. Thus, future
studies are assuredly going to examine
endosome dynamics and how they con-
tribute signaling events, which not only
affect gradient formation but differential
gene expression and cell fate.
HOW IS MEMBRANE TRAFFIC USED
BY HIGHLY DIFFERENTIATED CELLS TO
PERFORM SPECIALIZED CELL
FUNCTIONS?
Much of what we know about mem-
brane traffic comes from work performed
in workhorse cell lines like CHO, HeLa,
and HEK, primary cell cultures of neu-
rons, and genetically tractable cell types
such as yeast. However, these cells do
not reflect the diversity of cell types
found in the body, nor the special-
ized cell functions that are performed
by these highly differentiated cell types.
Moreover, there is significant variation in
the tissue-dependent expression of Rabs
(including highly related Rab isoforms and
housekeeping ones), effectors, and SNARE
proteins—proteins required to form and
regulate membrane trafficking pathways
(Gurkan et al., 2005). Thus, it is likely
that there are Rab-dependent trafficking
pathways that have not been adequately
studied, yet are critical for normal tissue
function and body homeostasis. A chal-
lenge for the future is to understand the
diversity of membrane trafficking events
in specialized cell types, the regulation
of these pathways, and how these traf-
ficking pathways contribute to specialized
cell function. Below, we provide just two
examples of cell types where membrane
traffic plays important functions that are
only now being explored.
UMBRELLA CELLS
Umbrella cells are polarized epithelial cells
that form the outermost cell layer of
the urothelium, the stratified tissue that
lines the lower urinary tract including
the kidney pelvis, ureters, and bladder
(Khandelwal et al., 2009). Because the
bladder forms the equivalent of a hollow
bag, it is possible to open it and study
the urothelium ex vivo, making it a par-
ticularly attractive model for cell studies.
An important feature of the urothelium is
that it must accommodate large changes
in tissue stretch as urine is propelled
from the renal pelvis to the ureters, and
as the urine accumulates into the blad-
der prior to voiding. The umbrella cell
has a number of features that allow it to
adjust to this dynamic mechanical envi-
ronment (Khandelwal et al., 2009). One
is the ability of the umbrella cell to
undergo large cell shape changes: it is
somewhat cuboidal-shaped in the empty
bladder, but highly flat and squamous in
the filled bladder (Figure 5A). Second, the
tight junction ring significantly increases
in diameter, and returns to baseline within
5min of voiding (Carattino et al., 2013).
Third, and most relevant to this article
are the dynamic changes in apical surface
area. In response to bladder filling, the
apical surface area dramatically increases
(more than 100%), which results from
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FIGURE 5 | Dynamic cell shape and apical surface area changes in
bladder umbrella cells. (A) Cell shape changes in the urothelium that
accompany bladder filling and that occur after voiding. The upper panels are
cross-sections of frozen bladder tissue and the bottom panels are a 3D
reconstruction of whole-mounted tissue viewed en face. Cells are stained
with rhodamine phalloidin (red), which labels the cortical actin cytoskeleton,
and ToPro-3 (blue), which labels nuclei. In the upper panels, the
approximate cell borders of the umbrella cells are indicated by dashed
lines. The position of the junctional complex is marked with an arrow and
the first layer of intermediate cells is indicated by closed, white circles.
Images are used with permission and from Carattino et al. (2013) (B) Apical
cytoplasm of umbrella cells showing discoidal (marked with asterisks) and
fusiform shaped vesicles (DFV). Multivesicular, late endosomes (MVB) are
also shown. Figure is used with permission and is from Khandelwal et al.
(2009) (C) Model for regulation of clathrin-independent endocytosis in
umbrella cells. In response to voiding, tension is increased across the
serosal surfaces of the umbrella cell as the bladder smooth muscle
contracts and actively refolds the mucosal surface of the bladder. This
tension is sensed by basolaterally localized β1-integrins, which in response
to tension stimulate the activation of the PI3K and focal adhesion kinase
(FAK). In turn, these kinases stimulate the activity of RhoA, which likely
acts through the Rho kinase (ROCK) to stimulate rearrangements of the
actin cytoskeleton that promote dynamin-dependent endocytosis. The
internalized apical membrane proteins are delivered to peripheral
junction-associated endosomes (PJAEs), and then ultimately to late
endosomes/lysosomes. Some recycling may occur from PJAEs.
the regulated exocytosis of an abundant
population of subapical discoidal- and/or
fusiform-shaped vesicles (DFVs) (Lewis
and De Moura, 1982; Truschel et al., 2002;
Khandelwal et al., 2008; Yu et al., 2009b)
(Figure 5B). Upon voiding, the added api-
cal membrane is then rapidly endocy-
tosed, via a clathrin-independent pathway
(Khandelwal et al., 2010).
Like other exocytic events, release of
the DFVs is dependent on SNAREs, Rab
GTPases including Rab11a, Rab8a, and
their effector MyoVb (Born et al., 2003;
Khandelwal et al., 2008, 2013). Rab27b
and the “myelin and lymphocytic protein”
(MAL) are also likely to play a role in
these events (Chen et al., 2003; Zhou et al.,
2012a). While Rab11a and Rab8a may act
within a cascade (Khandelwal et al., 2013),
the relationship between these Rabs and
Rab27b is not clear. In response to bladder
filling DFV exocytosis occurs in two stages
(Balestreire and Apodaca, 2007; Yu et al.,
2009b). Early stage exocytosis occurs first
and requires fusion of a preexisting pool
of DFVs. It is triggered by an apical non-
selective cation channel, which is likely
stretch sensitive and conducts Ca2+ into
the cell (Yu et al., 2009b). The other, late-
stage pathway is initiated when the blad-
der reaches its filling capacity and likely
occurs in response to excess stretch. This
stage requires protein synthesis and new
Frontiers in Cell and Developmental Biology | Membrane Traffic September 2014 | Volume 2 | Article 52 | 12
Apodaca and Brown Challenges in membrane traffic research
secretion and is triggered in response to
HB-EGF cleavage, EGF receptor transac-
tivation, and ERK activation (Balestreire
and Apodaca, 2007). It is unknown if the
requirement for protein synthesis reflects
new DFV formation or synthesis of pro-
teins that are required for DFV exocyto-
sis. An intriguing question, but one that
still remains unanswered is how DFVs
are formed. The classical model pro-
poses that DFVs are a recycling pool
of vesicles, but recent studies indicate
that the major fate of apically internal-
ized membrane is delivery to lysosomes
(Khandelwal et al., 2008, 2010). Other
studies indicate that DFVs are unlikely to
be lysosome-related organelles (Guo et al.,
2009).
A striking aspect of umbrella cell biol-
ogy is the rapid recovery of cell shape
and the decrease in apical surface area
that accompanies voiding. Intriguingly,
umbrella cells lack clathrin-coated pits
or caveolae at their apical surfaces, indi-
cating that apical endocytosis may occur
exclusively by a clathrin- and caveolar-
independent pathway. Such pathways have
been described for several years but are
not well-understood, because they can
lack specific cargoes, carriers, inhibitors,
or machineries (Mayor and Pagano, 2007;
Sandvig et al., 2008; Hansen and Nichols,
2009), and some are only revealed when
other forms of endocytosis are inhib-
ited (Damke et al., 1994). The pathway
in umbrella cells is related to the RhoA
pathway described for the IL-2 receptor
(Lamaze et al., 2001; Khandelwal et al.,
2010). Both pathways require dynamin,
RhoA, actin, and cholesterol, but not
clathrin. Moreover, a related RhoA-
dependent, but clathrin-independent
pathway has been identified in yeast, but
the cargoes and function of this path-
way has not yet been described (Prosser
et al., 2011). One intriguing aspect of
the yeast pathway is that it is depen-
dent on formins, proteins that regulate
the actin and microtubule cytoskele-
ton (Prosser et al., 2011). But, it is not
known if the RhoA pathway in multicel-
lular organisms requires these proteins.
The current dogma is that regardless
of the pathway of entry, most cargoes
internalized by clathrin-independent
pathways are transported to Rab5- and
EEA1-positive endosomes (Mayor et al.,
2014). However, in umbrella cells api-
cally internalized cargoes are delivered
to EEA1-negative carriers, called periph-
eral junction-associated apical endosomes
(PJAEs), that are ZO-1 positive and appear
to deliver internalized apical membrane
to late endosomes/lysosomes (Khandelwal
et al., 2010). This indicates that differ-
entiated cells may use pathways that are
distinct from those found in fibroblasts
and their ilk.
Of particular interest, is the find-
ing that like exocytosis, endocytosis is
also triggered by stretch, but appar-
ently in response to refolding of the
epithelium that occurs in response to
contraction of the smooth muscle. The
machinery that senses this refolding
includes the β1-integrin, which is local-
ized to the basolateral surface of the
umbrella cells. In response to stretch,
the β1-integrin appears to signal through
phosphatidylinositol-3-kinase (PI3K) and
the “focal adhesion kinase” (FAK) to
stimulate RhoA activation (Khandelwal
et al., 2010) (Figure 5C). Whether other
molecules act upstream of the integrin, the
mechanisms by which FAK/PI3K activate
RhoA, and what RhoA does to potenti-
ate rapid endocytosis are all unknown at
this time. Interestingly, RhoA-dependent
phagocytosis is also dependent on β1-
integrin function (Dupuy and Caron,
2008), indicating some conservation
between these two clathrin-independent
pathways for endocytosis.
T CELLS AND THE IMMUNOLOGICAL
SYNAPSE
T-cells are a population of lymphocytes
that are critical for cell-mediated immu-
nity. They characteristically express the
T-cell receptor (TCR), a multicomponent
complex that contains α- and β-chains,
CD3 (which is comprised of either ε/δ or
ε/γ dimers), in some cases a ζ-chain homo-
dimer, as well as a number of accessory
proteins (Fu et al., 2014). T-cells can form
cell-cell interactions with other lympho-
cytes, with antigen-presenting cells, and
with cells that will be targeted for death. To
prevent bystander effects, the proper func-
tion of T-cells depends on the secretion
of mediators—be they cytokines or cyto-
toxic effector granules—in a directed and
localized fashion. This feat is accomplished
by the formation of an “immunological
synapse,” which is a specialized and
compartmentalized zone of interaction
between a lymphocyte and its target cell
(Griffiths et al., 2010; Angus and Griffiths,
2013) (Figure 6). Immunological synapses
have several important functions includ-
ing regulation of lymphocyte activation,
transfer of peptide-MHC complexes from
the antigen-presenting cell to the lym-
phocyte, and the vectorial secretion of
cytokines (e.g., in the case of TH cells) or
lytic granules (e.g., in the case of cytotoxic
T-cells).
In some regard, the T-cell and its tar-
get cell are forming a plasma membrane-
plasma membrane MCS, which promotes
the transfer of information between the
two cells. The synapse is comprised of
two major zones: the central supramolec-
ular activation complex (cSMAC), which
is comprised of the TCR, its co-receptors,
and its associated signaling proteins, and
the peripheral SMAC (pSMAC), which
is made up of proteins that form an
adhesion complex between the interact-
ing cells (Griffiths et al., 2010) (Figure 6).
Examples of the latter include the integrin
“leukocyte function-associated antigen-1”
(LFA-1) on the T-cell and the “intracel-
lular adhesion molecule” ICAM1 on the
target cell. Of relevance to this essay is the
finding that the de novo formation and the
function of the immunological synapse are
dependent on exocytosis and endocytosis.
The first step in synapse formation is
interaction between the T-cell and its tar-
get cell, which occurs between the TCR
and the peptide-MHC complex on the
target cell (Griffiths et al., 2010). This
interaction stimulates TCR-dependent sig-
naling, which depends on the action of
the Lck, Fyn, and ZAP-70 kinases, as well
as the “linker of activated T cells” (LAT).
The latter interacts with PLCγ, stimulat-
ing IP3-receptor-dependent Ca2+ release
from the ER and activation of several
downstream targets including NFAT (see
Figure 3). Because T-cell activation can
extend for several minutes to hours, store-
operated Ca2+ entry is a critical com-
ponent of T-cell function. Activation of
the T-cell leads to formation of integrin-
dependent cell-cell interactions. In addi-
tion, the actin cytoskeleton undergoes a
rapid reorganization that results in its loss
from the region of the nacent synapse and
polymerization at a region of cell cortex
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FIGURE 6 | The immunological synapse. Immunological synapses are
formed between T-cells and their cellular targets. The central
supramolecular activation complex (cSMAC) is comprised of the T-cell
receptor (TCR), its co-receptors, and its associated signaling proteins
(most of which are not shown). In contrast, the peripheral SMAC
(pSMAC) is formed by interactions between ICAM1 and LFA-1, which
bring the cells in close proximity. During synapse formation, the
centrioles are repositioned to just below the T-cell synaptic membrane,
prompting the recruitment of endosomes and the Golgi to this region of
the cell. The synapse allows for the recognition of antigen by the T-cell
and in the case of cytotoxic T-cells forms a focused site for the release
of cytotoxic effector granules. During synapse formation the TCR is
internalized by clathrin-dependent endocytosis or by phagocytosis (not
shown). The receptor can then be targeted to late endosomes/lysosomes
for degradation. To ensure a constant supply of TCRs, activated T-cells
promote the proteins kinase C (PKC)-dependent phosphorylation of
β-arrestin, which interacts with “bystander TCRs” not present in the
synapse. Bound to β-arrestin, the bystander TCR is endocytosed and
then delivered by transcytosis to the synaptic membrane domain where
it can extend the period of signaling within the synapse.
surrounding the pSMAC in a region called
the dSMAC (Ritter et al., 2013). Strikingly,
the centrosome (and its associated cen-
trioles) moves to a position just below
the synapse, followed by movement of the
Golgi and recycling endosomes to a simi-
lar location (Figure 6). The space created
between the cells is then sealed off by the
pSMAC.
This organization is very similar to the
early steps of lumen formation described
in epithelial cysts (Bryant et al., 2010;
Apodaca et al., 2012). In both cases, there
is a requirement for polarity proteins, reor-
ganization of the cytoskeleton, a repo-
sitioning of the secretory and endocytic
organelles, and establishment of special-
ized cell-cell junctions that generate a
distinct membrane domain (the apical
domain in the case of epithelial cells)
(Apodaca et al., 2012; Angus and Griffiths,
2013; Ritter et al., 2013). These simi-
larities indicate that the machinery that
drives both processes may overlap and
should provide a fertile ground for future
exploration.
Activation of the TCR complex is reg-
ulated by several factors including the
assembly of the TCR complex and the
strength of the receptor’s signal. Prior to
assembly, the intracellular subunits of the
TCR-CD3 complex undergo constitutive
recycling. Moreover, Lck and Lat are
expressed in what appear to be dis-
tinct membrane populations (Schade and
Levine, 2002), and may use discrete traf-
ficking pathways to the cell surface (Soares
et al., 2013). However, the nature of
these pathways and the regulatory pro-
teins that govern them are poorly under-
stood. Association of Lck with the CD4 or
CD8 accessory chains of the TCR appears
to require Rab11a-dependent recycling
(Gorska et al., 2009). Moreover, Lck is also
associated with MAL, and the Lck activa-
tor protein Unc119. The former results in
the sorting of Lck and LAT to the center
of the immunological synapse. Other Rabs
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implicated in synapse formation include
Rab35 and its effector EPI64C (Patino-
Lopez et al., 2008), but how, or if, Rab35
interacts with the putative Rab11a cas-
cade has not been described. In polarized
epithelial secretion, Rab11a often oper-
ates as an upstream partner in a cas-
cade that includes Rab8 and Rab27/Rab3a
(Apodaca et al., 2012). Whether a simi-
lar system operates in the formation or
operation of the immunological synapse
has not been directly addressed, although
Rab11a and Rab27a were previously impli-
cated in release of cytotoxic granules in
cytotoxic T-cells (Stinchcombe et al., 2001;
Menager et al., 2007; Menasche et al.,
2008). Interestingly, TCRζ transport to the
synapse requires the intraflagellar trans-
port machinery (Finetti et al., 2009),
which is critical for formation of cilia,
but the details of this process are still
in their infancy. There are other simi-
larities between cilia formation and the
immunological synapse (Griffiths et al.,
2010).
An important role for TCR endocyto-
sis continues once the synapse is formed
(Griffiths et al., 2010). Once TCRs inter-
act with MHC/peptide at the periphery of
the forming synapse, they move centripi-
tally in the central region of the cSMAC.
Here, TCR signaling is terminated as a
result of phagocytosis and/or receptor-
mediated endocytosis. Furthermore, the
lymphocyte can be induced to internal-
ize the peptide-MHC complexes (includ-
ing bits of the target cell cytoplasm)
in a process called trogocytosis, a pro-
cess that depends on TC21 and RhoG
(Ahmed et al., 2008; Martinez-Martin
et al., 2011). In contrast, the signaling
molecules involved in the initial activa-
tion of the T-cell (e.g., Zap70, LAT) appear
to be excluded from the TCR microclus-
ters and their signal diminishes after ini-
tial delivery to the synapse (Balagopalan
et al., 2007), possibly a result of internal-
ization. Indeed LAT may be internalized
in a Cbl- and ubiquitin-dependent reac-
tion (Balagopalan et al., 2007). Because
the synapse can exist on a minute to
hour timescale, it is important to have
a mechanism to recruit bystander TCRs
(those not engaged with peptide/MHC)
to the synapse. One mechanism to pro-
mote this recruitment is via β-arrestin1,
a well-known adaptor protein that is
critical for clathrin-dependent internal-
ization of G-protein coupled receptors.
Upon engagement with peptide/MHC,
those TCRs in the synapse trigger a PKC-
dependent phosphorylation of β-arrestin1
at Ser163, stimulating β-arrestin1 binding
to non-phosphorylated, inactive bystander
TCRs (Fernandez-Arenas et al., 2014)
(Figure 6). Endocytosis of the latter ulti-
mately results in their relocalization to
the immunological synapse, where T-cell
signaling can be sustained. The machin-
ery that specifies their transcytosis from
the free surface to the synaptic membrane
is largely unknown, but dependent on
β-arrestin1.
An interesting question is whether all
membrane traffic is directed toward the
immunological synapse of “activated” T-
cells. In the case of TH cells, it appears that
some cytokines are released in a directed
fashion, whereas others are not (Huse
et al., 2006; Bertrand et al., 2010). On its
face, this indicates that upon activation, T-
cells must either use their existing machin-
ery in novel ways, or perhaps synthesize
new machinery to ensure polarized secre-
tion. The nature of the polarized secre-
tory machinery is mostly unknown, but as
noted above, work in polarized epithelial
cells can provide a large number of sorting
and regulatory proteins as potential targets
(Apodaca et al., 2012). Finally, it is possible
that there are other novel mechanisms of
secretion that may ensure polarized deliv-
ery of cargo. For example, in activated
T-cells Golgi stacks appear to abut next to
the plasma membrane, perhaps indicating
the formation of an MCSs with the synap-
tic membrane domain (Stinchcombe et al.,
2006). While the nature of this interac-
tion and its role in secretion remains to be
explored, it indicates that there are numer-
ous things to be learned about how spe-
cialized membrane domains are created,
maintained, and how they perform special
functions. Furthermore, this information
is likely to be useful to other cell types
including the osteoclast, a bone-degrading
cell that forms a synapse-like structure
called the “ruffled border” when in con-
tact with the bone matrix (Stenbeck and
Coxon, 2014).
FINAL WORDS
The important take home point of this
essay is that there are many new and
exciting areas of research that are in their
infancy and will require years to under-
stand. Moreover, there are other exciting
areas of research that we have not dis-
cussed, but explore fundamental aspects
of membrane traffic in normal and dis-
ease states. A few of these include: (1)
understanding how membrane curvature
is regulated to form coated vesicles or
membrane tubules (Bechler et al., 2012;
Ha et al., 2012); (2) elucidating the global
coordination of lipid metabolism, mem-
brane biogenesis, and organelle homeosta-
sis (Henry et al., 2014); (3) manipulating
membrane trafficking pathways (e.g., via
interventions in phosphoinositide signal-
ing) to control tumorigenesis and intra-
cellular pathogens (Balla, 2013); and (4)
elucidating and manipulating the mem-
brane trafficking pathways of proteins that
contribute to pathologies including the
Alzheimer’s disease β-amyloid precursor
protein and others leading to neurodegen-
erative disorders (Zhang et al., 2012). A
final Grand Challenge, perhaps the grand-
est of all, is to elucidate the evolution-
ary origins of eukaryotic endomembrane
systems, i.e., the secretory and endocytic
pathways. Ironically, and in spite of the
tremendous advances in our understand-
ing of secretion and endocytosis, little is
known about how cells evolved to establish
these membrane systems (Dacks and Field,
2007; Jekely, 2007). Although much can be
inferred from comparative genomics, our
understanding of the evolutionary mech-
anisms by which eukaryotic endomem-
brane systems developed is rudimentary
at best. While the field of membrane traf-
fic is well-established, there is much that
remains to be accomplished in the next
decade. We hope that this article will
inspire new, and established, investiga-
tors to pursue these challenging areas of
investigation.
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